Unknown PHASE3 INTERVENTIONAL 3-arm NCT05138029

Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time OCT During Operation

Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time Optical Coherence Tomography During Operation

Sponsor: Affiliated Hospital of Nantong University

Conditions Diabetic Retinopathy

Interventions Dexamethasone intravitreal implant Inner limiting membrane stripping Ranibizumab Injection [Lucentis]

Updated 7 times since 2021 Last updated: Jul 28, 2023 Started: Nov 15, 2021 Primary completion: Dec 31, 2023 Completion: May 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Diabetic Retinopathy, this trial is ongoing. The trial is conducted by Affiliated Hospital of Nantong University and has accumulated 7 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Aug 2025 — Present [monthly]

Unknown PHASE3

Status: Recruiting → Unknown
Sep 2024 — Aug 2025 [monthly]

Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE3
Sep 2023 — Jul 2024 [monthly]

Recruiting PHASE3
Apr 2022 — Sep 2023 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Jan 2022 — Apr 2022 [monthly]

Not Yet Recruiting PHASE3
Dec 2021 — Jan 2022 [monthly]

Not Yet Recruiting PHASE3

First recorded

Nov 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Affiliated Hospital of Nantong University

Data source: Affiliated Hospital of Nantong University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nantong, China